Initiating Early Control of Migraine Pain and Associated Symptoms
Trial details
- Registry ID
- NCT04163185
- Phase
- Phase 3
Drug identity checked against registry records
Also recorded as AXS-07; MoSEIC meloxicam and rizatriptan
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Initiating Early Control of Migraine Pain and Associated SymptomsNCT04163185 | AXSM | Phase 3 | Completed | 2020-03-16Actual |
| Maximizing Outcomes in Treating Acute MigraineNCT03896009 | AXSM | Phase 3 | Completed | 2019-12-10Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |